Multiomics Market Size to Hit USD 11.79 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sourcehs

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Multiomics Market

5.1. COVID-19 Landscape: Multiomics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Multiomics Market, By Omics Type

8.1. Multiomics Market Revenue and Volume, by Omics Type

8.1.1. Genomics

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Transcriptomics

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Proteomics

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Metabolomics

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Epigenomics

8.1.5.1. Market Revenue and Volume Forecast

8.1.6. Microbiomics

8.1.6.1. Market Revenue and Volume Forecast

8.1.7. Lipidomics

8.1.7.1. Market Revenue and Volume Forecast

Chapter 9. Global Multiomics Market, By Application

9.1. Multiomics Market Revenue and Volume, by Application

9.1.1. Drug Discovery & Development

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Precision Medicine & Personalized Therapy

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Biomarker Identification

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Clinical Diagnostics

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Agriculture & Crop Research

9.1.5.1. Market Revenue and Volume Forecast

9.1.6. Nutrigenomics

9.1.6.1. Market Revenue and Volume Forecast

9.1.7. Infectious Disease Surveillance

9.1.7.1. Market Revenue and Volume Forecast

9.1.8. Systems Biology Research

9.1.8.1. Market Revenue and Volume Forecast

Chapter 10. Global Multiomics Market, By Technology

10.1. Multiomics Market Revenue and Volume, by Technology

10.1.1. Next-Generation Sequencing (NGS)

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Mass Spectrometry (MS)

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Microarrays

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Single-Cell Analysis

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Real-Time PCR

10.1.5.1. Market Revenue and Volume Forecast

10.1.6. Multiomics Integration Platforms (AI/ML-based)

10.1.6.1. Market Revenue and Volume Forecast

Chapter 11. Global Multiomics Market, By Offering

11.1. Multiomics Market Revenue and Volume, by Offering

11.1.1. Software & Services

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Cloud-Based Omics Platforms

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Instruments

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Consumables

11.1.4.1. Market Revenue and Volume Forecast

Chapter 12. Global Multiomics Market, By End User

12.1. Multiomics Market Revenue and Volume, by End User

12.1.1. Pharmaceutical & Biotechnology Companies

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Academic & Research Institutions

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Contract Research Organizations (CROs)

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Hospitals & Clinics

12.1.4.1. Market Revenue and Volume Forecast

12.1.5. Government & Public Health Agencies

12.1.5.1. Market Revenue and Volume Forecast

Chapter 13. Global Multiomics Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Omics Type

13.1.2. Market Revenue and Volume Forecast, by Application

13.1.3. Market Revenue and Volume Forecast, by Technology

13.1.4. Market Revenue and Volume Forecast, by Offering

13.1.5. Market Revenue and Volume Forecast, by End User

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Omics Type

13.1.6.2. Market Revenue and Volume Forecast, by Application

13.1.6.3. Market Revenue and Volume Forecast, by Technology

13.1.6.4. Market Revenue and Volume Forecast, by Offering

13.1.6.5. Market Revenue and Volume Forecast, by End User

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Omics Type

13.1.7.2. Market Revenue and Volume Forecast, by Application

13.1.7.3. Market Revenue and Volume Forecast, by Technology

13.1.7.4. Market Revenue and Volume Forecast, by Offering

13.1.7.5. Market Revenue and Volume Forecast, by End User

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Omics Type

13.2.2. Market Revenue and Volume Forecast, by Application

13.2.3. Market Revenue and Volume Forecast, by Technology

13.2.4. Market Revenue and Volume Forecast, by Offering

13.2.5. Market Revenue and Volume Forecast, by End User

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Omics Type

13.2.6.2. Market Revenue and Volume Forecast, by Application

13.2.6.3. Market Revenue and Volume Forecast, by Technology

13.2.7. Market Revenue and Volume Forecast, by Offering

13.2.8. Market Revenue and Volume Forecast, by End User

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Omics Type

13.2.9.2. Market Revenue and Volume Forecast, by Application

13.2.9.3. Market Revenue and Volume Forecast, by Technology

13.2.10. Market Revenue and Volume Forecast, by Offering

13.2.11. Market Revenue and Volume Forecast, by End User

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Omics Type

13.2.12.2. Market Revenue and Volume Forecast, by Application

13.2.12.3. Market Revenue and Volume Forecast, by Technology

13.2.12.4. Market Revenue and Volume Forecast, by Offering

13.2.13. Market Revenue and Volume Forecast, by End User

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Omics Type

13.2.14.2. Market Revenue and Volume Forecast, by Application

13.2.14.3. Market Revenue and Volume Forecast, by Technology

13.2.14.4. Market Revenue and Volume Forecast, by Offering

13.2.15. Market Revenue and Volume Forecast, by End User

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Omics Type

13.3.2. Market Revenue and Volume Forecast, by Application

13.3.3. Market Revenue and Volume Forecast, by Technology

13.3.4. Market Revenue and Volume Forecast, by Offering

13.3.5. Market Revenue and Volume Forecast, by End User

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Omics Type

13.3.6.2. Market Revenue and Volume Forecast, by Application

13.3.6.3. Market Revenue and Volume Forecast, by Technology

13.3.6.4. Market Revenue and Volume Forecast, by Offering

13.3.7. Market Revenue and Volume Forecast, by End User

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Omics Type

13.3.8.2. Market Revenue and Volume Forecast, by Application

13.3.8.3. Market Revenue and Volume Forecast, by Technology

13.3.8.4. Market Revenue and Volume Forecast, by Offering

13.3.9. Market Revenue and Volume Forecast, by End User

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Omics Type

13.3.10.2. Market Revenue and Volume Forecast, by Application

13.3.10.3. Market Revenue and Volume Forecast, by Technology

13.3.10.4. Market Revenue and Volume Forecast, by Offering

13.3.10.5. Market Revenue and Volume Forecast, by End User

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Omics Type

13.3.11.2. Market Revenue and Volume Forecast, by Application

13.3.11.3. Market Revenue and Volume Forecast, by Technology

13.3.11.4. Market Revenue and Volume Forecast, by Offering

13.3.11.5. Market Revenue and Volume Forecast, by End User

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Omics Type

13.4.2. Market Revenue and Volume Forecast, by Application

13.4.3. Market Revenue and Volume Forecast, by Technology

13.4.4. Market Revenue and Volume Forecast, by Offering

13.4.5. Market Revenue and Volume Forecast, by End User

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Omics Type

13.4.6.2. Market Revenue and Volume Forecast, by Application

13.4.6.3. Market Revenue and Volume Forecast, by Technology

13.4.6.4. Market Revenue and Volume Forecast, by Offering

13.4.7. Market Revenue and Volume Forecast, by End User

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Omics Type

13.4.8.2. Market Revenue and Volume Forecast, by Application

13.4.8.3. Market Revenue and Volume Forecast, by Technology

13.4.8.4. Market Revenue and Volume Forecast, by Offering

13.4.9. Market Revenue and Volume Forecast, by End User

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Omics Type

13.4.10.2. Market Revenue and Volume Forecast, by Application

13.4.10.3. Market Revenue and Volume Forecast, by Technology

13.4.10.4. Market Revenue and Volume Forecast, by Offering

13.4.10.5. Market Revenue and Volume Forecast, by End User

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Omics Type

13.4.11.2. Market Revenue and Volume Forecast, by Application

13.4.11.3. Market Revenue and Volume Forecast, by Technology

13.4.11.4. Market Revenue and Volume Forecast, by Offering

13.4.11.5. Market Revenue and Volume Forecast, by End User

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Omics Type

13.5.2. Market Revenue and Volume Forecast, by Application

13.5.3. Market Revenue and Volume Forecast, by Technology

13.5.4. Market Revenue and Volume Forecast, by Offering

13.5.5. Market Revenue and Volume Forecast, by End User

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Omics Type

13.5.6.2. Market Revenue and Volume Forecast, by Application

13.5.6.3. Market Revenue and Volume Forecast, by Technology

13.5.6.4. Market Revenue and Volume Forecast, by Offering

13.5.7. Market Revenue and Volume Forecast, by End User

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Omics Type

13.5.8.2. Market Revenue and Volume Forecast, by Application

13.5.8.3. Market Revenue and Volume Forecast, by Technology

13.5.8.4. Market Revenue and Volume Forecast, by Offering

13.5.8.5. Market Revenue and Volume Forecast, by End User

Chapter 14. Company Profiles

14.1. Illumina, Inc

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Agilent Technologies

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. QIAGEN

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Bruker Corporation

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. BGI Genomics

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. PerkinElmer

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Waters Corporation

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Bio-Rad Laboratories

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. 10x Genomics

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The multiomics market size is expected to increase from USD 2.81 billion in 2024 to USD 11.79 billion by 2034.

The multiomics market is expected to grow at a compound annual growth rate (CAGR) of around 15.42% from 2025 to 2034.

The major players in the multiomics market include Thermo Fisher Scientific, Illumina, Inc., Agilent Technologies, QIAGEN, Bruker Corporation, BGI Genomics, PerkinElmer, Waters Corporation, Bio-Rad Laboratories, and 10x Genomics.

The driving factors of the multiomics market are the rising prevalence of chronic diseases, including cancer, diabetes, and cardiovascular diseases, is driving the demand for multiomics.

North America region will lead the global multiomics market during the forecast period 2025 to 2034.